Aldosterone and the autocrine modulation of potassium currents and oxidative stress in the diabetic rat heart.

British Journal of Pharmacology
Y ShimoniG Kargacin

Abstract

Aldosterone plays a major role in cardiac pathology. This study was designed to investigate the role of cardiac aldosterone in modulating K(+) currents and oxidative stress in the streptozotocin-induced diabetic rat heart. Transient and sustained K(+) currents were measured in ventricular myocytes by voltage clamp. Plasma and cellular aldosterone were measured by ELISA. Fluorescent dihydroethidium (DHE) was used to assess superoxide ions as markers of oxidative stress. The mineralocorticoid antagonist spironolactone (1 microM, 5-9 h) significantly augmented both K(+) currents in diabetic males, with a concomitant shortening of the action potential but had no effect in myocytes from control males or from diabetic females. Effects of spironolactone were restored in ovariectomized diabetic females and abolished in orchidectomized diabetic males. The aldosterone synthase inhibitor FAD286 (1 microM, 5-9 h) significantly augmented K(+) currents in cells from diabetic males, but not females. Spironolactone and FAD286 significantly reduced oxidative stress in cells from diabetic males. Plasma aldosterone content was elevated in diabetic males (relative to control), but not in females. Cellular aldosterone was also elevated, but not sig...Continue Reading

References

Jul 1, 1994·Pflügers Archiv : European journal of physiology·P Daleau, J Turgeon
Sep 1, 1996·Diabetes Care·K AboT Kazumi
Mar 28, 1998·The Journal of Biological Chemistry·J S SilvestreC Delcayre
Mar 21, 1998·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·T NakayamaK Kanmatsuse
May 21, 1999·British Journal of Clinical Pharmacology·A D Struthers
Jun 18, 1999·Journal of Molecular and Cellular Cardiology·S H SlightK T Weber
Aug 19, 1999·Cell Biochemistry and Function·B UstündagN Ilhan
Oct 28, 1999·Cardiovascular Research·G P RossiA C Pessina
Apr 12, 2000·Kidney International·C DelcayreV Robert
Apr 26, 2000·Laboratory Investigation; a Journal of Technical Methods and Pathology·F FiordalisoJ Kajstura
Jan 11, 2000·Circulation Research·A FrustaciP Anversa
Apr 25, 2001·Diabetic Medicine : a Journal of the British Diabetic Association·P RossingH H Parving
Nov 10, 2001·The Journal of Clinical Endocrinology and Metabolism·M J YoungJ W Funder
Nov 17, 2001·The Journal of Physiology·J P BénitahG Vassort
Feb 28, 2002·Cardiovascular Research·Marcus FischerHeribert Schunkert
Nov 5, 2002·The American Journal of Pathology·Yao SunKarl T Weber
Jan 14, 2003·Archives of Internal Medicine·Arshag D Mooradian
Jan 16, 2003·The Journal of Physiology·Judith BrouilletteCéline Fiset
Feb 8, 2003·The Journal of Clinical Endocrinology and Metabolism·Samy I McFarlane, James R Sowers
Mar 11, 2003·American Journal of Physiology. Heart and Circulatory Physiology·Yakhin Shimoni, Xiu-Fang Liu
Apr 2, 2003·The New England Journal of Medicine·Bertram PittUNKNOWN Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study Investigators
Jun 5, 2003·The Journal of Physiology·Yakhin Shimoni, Xiu-Fang Liu
Sep 30, 2003·Diabetes Care·David S H Bell
Apr 14, 2004·Circulation·Frédéric MichelJean-Sébastien Silvestre
Apr 17, 2004·Kidney International·Norman K HollenbergNaomi D L Fisher
Apr 17, 2004·American Journal of Physiology. Heart and Circulatory Physiology·Yakhin Shimoni, Xiu-Fang Liu
Apr 28, 2004·Trends in Endocrinology and Metabolism : TEM·John W Funder
May 11, 2004·Current Diabetes Reports·Fadi A El-AtatJ Thomas Bigger
Aug 17, 2004·Endocrinology·Elise P Gomez-SanchezCelso E Gomez-Sanchez
Sep 15, 2004·Archives of Internal Medicine·Hoong Sern LimGregory Y H Lip
Dec 2, 2004·Canadian Journal of Physiology and Pharmacology·David L Severson
Dec 23, 2004·Journal of Cardiovascular Pharmacology·Romain BosPhilippe Lechat
Feb 26, 2005·Clinical and Experimental Pharmacology & Physiology·Kiyoshi MatsumuraMitsuo Iida

❮ Previous
Next ❯

Citations

May 12, 2010·Cardiovascular Toxicology·Guy Vassort, Belma Turan
Mar 21, 2012·Antioxidants & Redox Signaling·Daniela Zablocki, Junichi Sadoshima
Oct 30, 2013·Clinical and Experimental Hypertension : CHE·David Z I Cherney, Alberto Montanari
Mar 25, 2009·Pharmacological Reports : PR·Ludovic BenardClaude Delcayre
Jun 15, 2013·British Journal of Pharmacology·Loubina FazalJane-Lise Samuel
Apr 18, 2017·Stress : the International Journal on the Biology of Stress·Agnesa CsanovaDaniela Jezova
Jun 1, 2018·International Journal of Endocrinology·Simón Quetzalcóatl Rodríguez-LaraAlejandra Guillermina Miranda-Díaz
Dec 17, 2008·Journal of Medicinal Chemistry·Christina M ThompsonPaul J Hergenrother

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.